Atherton, CA, United States of America

Lawrence C Horowitz

USPTO Granted Patents = 11 


 

Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 87(Granted Patents)


Location History:

  • Atherton, CA (US) (2012 - 2019)
  • Mountain View, CA (US) (2020)

Company Filing History:


Years Active: 2012-2020

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Lawrence C. Horowitz

Introduction

Lawrence C. Horowitz is a prominent inventor based in Atherton, California, known for his significant contributions to the field of biotechnology. With a total of 11 patents to his name, he has made remarkable advancements in the development of therapeutic antibodies and binding proteins.

Latest Patents

Among his latest patents, Horowitz has developed anti-surrogate light chain antibodies, which focus on the use of anti-VpreB1 antibodies. This invention addresses critical applications in medical science. Additionally, he has created sur-binding proteins against ERBB3, which involve constructs that can bind to ErbB3 and explore various aspects related to these constructs.

Career Highlights

Horowitz has worked with notable companies such as I2 Pharmaceuticals, Inc. and Sea Lane Biotechnologies, LLC. His work in these organizations has contributed to the advancement of biotechnological innovations and therapeutic solutions.

Collaborations

Some of his notable coworkers include Ramesh Bhatt and Arun K. Kashyap, who have collaborated with him on various projects, enhancing the scope of his research and inventions.

Conclusion

Lawrence C. Horowitz's innovative work in biotechnology, particularly in the development of antibodies and binding proteins, showcases his significant impact on the field. His contributions continue to influence advancements in medical science and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…